US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Everus Construction Group, Inc.

123.35

+3.723.11%

Post-market: 123.350.00000.00%19:30 EDT

Volume:415.36K

Turnover:51.58M

Market Cap:6.29B

PE:24.77

High:125.74

Open:122.40

Low:121.64

Close:119.63

52wk High:171.58

52wk Low:78.14

Shares:51.01M

Float Shares:50.85M

Volume Ratio:1.27

T/O Rate:0.82%

Dividend:- -

Dividend Rate:- -

EPS(TTM):4.98

EPS(LYR):3.95

ROE:39.52%

ROA:11.68%

PB:8.14

PE(LYR):31.23

Loading ...

Overview Company News Filings

Quest Diagnostics (DGX) Could Be 6% Undervalued After Florida ECG Screening Push

Simply Wall St.

Milestone Pharmaceuticals Enrolls First Canadian Study Participant in ReVeRA-301 Phase 3 Pivotal Trial Evaluating Etripamil Nasal Spray for AFib-RVR

Everus Construction Group - Enters First Amendment to Credit Agreement on Sept 1, 2026 - SEC Filing

THOMSON REUTERS

Everus Construction Group - Increases Term Loans by $200 Mln to Total $477.50 Mln - SEC Filing

THOMSON REUTERS

Everus Construction Amends JPMorgan-Led Credit Agreement, Ups Term Loan to $477.5 Million

Everus Construction Group Management to Attend Jefferies Renewables and D.A. Davidson Investor Conferences

Everus Closes $295 Million Cash Acquisition of Epsilon Industries

MT Newswires Live

Everus Completes Acquisition of Epsilon Industries

THOMSON REUTERS

Everus Construction Group - to Update Fy2026 Financial Forecast Including Epsilon Impact During Q3 Earnings

THOMSON REUTERS

How Rising Analyst Earnings Estimates At Everus Construction Group (ECG) Have Changed Its Investment Story

Simply Wall St.

Everus Construction Group (ECG) Could Be 32% Below Fair Value Following Analyst Upgrades

Simply Wall St.

Everus Construction Group Initiated at Buy by DA Davidson

Milestone Pharmaceuticals Initiates Pivotal Phase 3 Trial of Etripamil Nasal Spray for Self-Administered Treatment of Atrial Fibrillation with Rapid Ventricular Rate (AFib-RVR)

U.S. Research Roundup-Health Catalyst, Nektar Therapeutics, TIC Solutions

Everus Construction initiated with a Buy at DA Davidson

U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Patients with Tourette Syndrome

Everus Construction Director David M. Sparby Acquires 1,000 Common Shares for $144,950

NeuralCloud to Pilot AI ECG Platforms with Island Mobile Cardiology Testing

Everus Construction Group Price Target Cut to $152.00/Share from $174.00 by Cantor Fitzgerald

Milestone Pharmaceuticals Announces Second Quarter 2026 Financial Results and Provides Corporate Update

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/ECG/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ECG","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ECG\",,,,,undefined,":{"symbol":"ECG","market":"US","secType":"STK","nameCN":"Everus Construction Group, Inc.","latestPrice":123.35,"timestamp":1790971200000,"preClose":119.63,"halted":0,"volume":415361,"hourTrading":{"tag":"盘后","latestPrice":123.35,"preClose":123.35,"latestTime":"19:30 EDT","volume":11408,"amount":1407176.8,"timestamp":1790983808004,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.03109587896012705,"floatShares":50847531,"shares":51006575,"eps":4.980016,"marketStatus":"Market Closed","change":3.72,"latestTime":"10-02 16:00:00 EDT","open":122.4,"high":125.74,"low":121.64,"amount":51575792.807804994,"amplitude":0.034272,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":4.980016,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"exchange":"NYSE","adjPreClose":119.63,"preHourTrading":{"tag":"盘前","latestPrice":121.8,"preClose":119.63,"latestTime":"09:02 EDT","volume":3,"amount":364.38,"timestamp":1790946173427,"change":2.17,"changeRate":0.018139,"amplitude":0.008526},"postHourTrading":{"tag":"盘后","latestPrice":123.35,"preClose":123.35,"latestTime":"19:30 EDT","volume":11408,"amount":1407176.8,"timestamp":1790983808004,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.2650709555447275,"impliedVol":0.6499,"impliedVolPercentile":0.6375},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ECG\",,,,,undefined,":{"symbol":"ECG","floatShares":50847531,"roa":"11.68%","roe":"39.52%","lyrEps":3.95,"volumeRatio":1.2650709555447275,"shares":51006575,"dividePrice":0,"high":125.74,"amplitude":0.034272,"preClose":119.63,"low":121.64,"week52Low":78.14,"pbRate":"8.14","psRate":"1.47","week52High":171.577,"institutionHeld":0,"latestPrice":123.35,"eps":4.980016,"divideRate":0,"volume":415361,"delay":0,"ttmEps":4.980016,"open":122.4,"prevYearClose":85.56,"prevWeekClose":116.94,"prevMonthClose":117.52,"prevQuarterClose":117.52,"fiveDayClose":116.94,"twentyDayClose":115.05,"sixtyDayClose":138.64},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ECG\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-04","symbol":"ECG","fiscalQuarterEnding":"2026/06","expectedEps":1.1,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785816000000,"reportTimeType":"post","actualEps":1.64},{"market":"US","date":"2026-05-05","symbol":"ECG","fiscalQuarterEnding":"2026/03","expectedEps":0.76,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1777953600000,"reportTimeType":"post","actualEps":1.14},{"date":"2026-02-24","symbol":"ECG","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/12","expectedEps":0.72,"defaultRemindTime":1771966800000,"name":null,"time":"Post-Mkt","dateTimestamp":1771909200000,"actualEps":null},{"market":"US","date":"2025-11-04","symbol":"ECG","fiscalQuarterEnding":"2025/09","expectedEps":0.62,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762232400000,"reportTimeType":"post","actualEps":1.11},{"market":"US","date":"2025-08-12","symbol":"ECG","fiscalQuarterEnding":"2025/06","expectedEps":0.61,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":1.03}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ECG\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ECG\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.375,"buy":0.25,"hold":0.375,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.25,"analysts":8,"updateTime":1787284800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ECG\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ECG","date":"2026-10-02","current":24.768997,"percent":0.370763,"low":11.94786,"twenty":22.672158,"median":24.973378,"eighty":29.537776,"high":38.646629,"avg":25.284789,"sd":5.744328,"marketCap":6108766700},"quantilePoints":[{"date":"2024-11-15","current":19.884731,"twenty":20.580031,"median":21.388177,"eighty":22.118522,"marketCap":2892154627},{"date":"2024-11-22","current":22.527151,"twenty":20.580031,"median":21.221711,"eighty":22.118522,"marketCap":3276483952},{"date":"2024-11-29","current":22.309869,"twenty":20.774883,"median":21.784189,"eighty":22.44935,"marketCap":3244881275},{"date":"2024-12-06","current":23.914946,"twenty":20.948708,"median":22.309869,"eighty":22.694667,"marketCap":3478333306},{"date":"2024-12-13","current":24.1112,"twenty":21.255005,"median":22.386969,"eighty":23.504916,"marketCap":3506877659},{"date":"2024-12-20","current":22.639296,"twenty":21.463875,"median":22.621773,"eighty":23.900227,"marketCap":3292795011},{"date":"2024-12-27","current":25.796882,"twenty":21.726014,"median":22.804009,"eighty":24.031297,"marketCap":3752053262},{"date":"2025-01-03","current":24.279418,"twenty":22.045628,"median":23.042317,"eighty":24.098584,"marketCap":3531344247},{"date":"2025-01-10","current":23.36123,"twenty":22.054038,"median":23.36123,"eighty":24.167273,"marketCap":3397797452},{"date":"2025-01-17","current":23.231562,"twenty":22.309869,"median":23.296396,"eighty":24.223346,"marketCap":3378937791},{"date":"2025-01-24","current":26.403166,"twenty":22.309869,"median":23.448843,"eighty":24.416796,"marketCap":3840234925},{"date":"2025-01-31","current":24.703467,"twenty":22.363139,"median":23.511925,"eighty":24.431515,"marketCap":3593020438},{"date":"2025-02-07","current":24.784071,"twenty":22.393278,"median":23.631079,"eighty":24.431515,"marketCap":3604744012},{"date":"2025-02-14","current":17.609659,"twenty":22.363139,"median":23.694161,"eighty":24.484083,"marketCap":2525594974},{"date":"2025-02-21","current":16.543269,"twenty":22.049833,"median":23.511925,"eighty":24.443431,"marketCap":2372652202},{"date":"2025-02-28","current":14.893919,"twenty":20.948708,"median":23.398027,"eighty":24.417497,"marketCap":2136100715},{"date":"2025-03-07","current":14.060071,"twenty":19.828659,"median":23.326185,"eighty":24.358924,"marketCap":2016509475},{"date":"2025-03-14","current":13.437787,"twenty":16.836882,"median":23.135188,"eighty":24.308591,"marketCap":1927260826},{"date":"2025-03-21","current":14.294761,"twenty":15.304834,"median":22.94419,"eighty":24.287829,"marketCap":2050168965},{"date":"2025-03-28","current":12.43502,"twenty":14.540119,"median":22.651562,"eighty":24.245775,"marketCap":1783443003},{"date":"2025-04-04","current":12.555921,"twenty":14.128344,"median":22.527151,"eighty":24.214935,"marketCap":1800782740},{"date":"2025-04-11","current":13.501793,"twenty":13.910012,"median":22.343162,"eighty":24.184095,"marketCap":1936440687},{"date":"2025-04-17","current":13.572911,"twenty":13.722422,"median":22.181953,"eighty":24.146246,"marketCap":1946640532},{"date":"2025-04-25","current":14.568566,"twenty":13.695946,"median":21.51434,"eighty":24.113303,"marketCap":2089438371},{"date":"2025-05-02","current":15.233522,"twenty":13.71017,"median":20.922073,"eighty":24.085968,"marketCap":2184806927},{"date":"2025-05-09","current":17.164381,"twenty":13.722422,"median":19.902399,"eighty":24.031297,"marketCap":2461732735},{"date":"2025-05-16","current":20.563833,"twenty":13.745616,"median":19.893565,"eighty":23.999055,"marketCap":3123214340},{"date":"2025-05-23","current":21.992869,"twenty":13.78911,"median":20.563833,"eighty":23.959104,"marketCap":2926865953},{"date":"2025-05-30","current":22.176813,"twenty":13.823958,"median":20.788901,"eighty":23.91004,"marketCap":2951345752},{"date":"2025-06-06","current":23.146354,"twenty":13.877297,"median":21.451259,"eighty":23.877799,"marketCap":3080374692},{"date":"2025-06-13","current":23.161683,"twenty":13.948415,"median":21.770602,"eighty":23.816119,"marketCap":3082414675},{"date":"2025-06-20","current":22.912591,"twenty":13.971173,"median":22.043525,"eighty":23.771261,"marketCap":3049264947},{"date":"2025-06-27","current":23.740342,"twenty":14.060071,"median":22.121246,"eighty":23.740342,"marketCap":3159424042},{"date":"2025-07-03","current":24.970471,"twenty":14.07145,"median":22.251005,"eighty":23.895321,"marketCap":3323132697},{"date":"2025-07-11","current":25.805886,"twenty":14.153947,"median":22.376456,"eighty":24.052477,"marketCap":3434311784},{"date":"2025-07-18","current":26.518671,"twenty":14.202307,"median":22.526346,"eighty":24.175684,"marketCap":3529171005},{"date":"2025-07-25","current":26.442027,"twenty":14.212264,"median":22.621773,"eighty":24.30109,"marketCap":3518971089},{"date":"2025-08-01","current":28.457753,"twenty":14.278404,"median":22.671329,"eighty":24.416796,"marketCap":3787228885},{"date":"2025-08-08","current":27.411568,"twenty":14.30614,"median":22.782297,"eighty":24.537352,"marketCap":3648000028},{"date":"2025-08-15","current":23.175295,"twenty":14.422774,"median":22.810398,"eighty":24.635911,"marketCap":3841305163},{"date":"2025-08-22","current":23.323006,"twenty":14.493892,"median":22.904927,"eighty":24.537352,"marketCap":3865788319},{"date":"2025-08-29","current":24.713955,"twenty":14.521629,"median":22.920255,"eighty":24.537352,"marketCap":4096338038},{"date":"2025-09-05","current":23.815378,"twenty":14.551498,"median":22.978193,"eighty":24.507914,"marketCap":3947398839},{"date":"2025-09-12","current":24.372372,"twenty":14.649641,"median":23.042317,"eighty":24.488989,"marketCap":4039720740},{"date":"2025-09-19","current":25.200171,"twenty":14.753844,"median":23.089828,"eighty":24.488989,"marketCap":4176928426},{"date":"2025-09-26","current":24.396991,"twenty":14.851263,"median":23.146354,"eighty":24.588002,"marketCap":4043801266},{"date":"2025-10-03","current":25.117084,"twenty":14.97923,"median":23.180649,"eighty":24.722376,"marketCap":4163156651},{"date":"2025-10-10","current":27.003481,"twenty":15.154555,"median":23.193759,"eighty":24.845751,"marketCap":4475826956},{"date":"2025-10-17","current":27.852821,"twenty":15.383802,"median":23.275964,"eighty":25.02914,"marketCap":4616605103},{"date":"2025-10-24","current":26.926548,"twenty":15.791108,"median":23.323006,"eighty":25.217404,"marketCap":4463075312},{"date":"2025-10-31","current":27.600481,"twenty":16.024903,"median":23.341955,"eighty":25.414653,"marketCap":4574779711},{"date":"2025-11-07","current":27.713121,"twenty":16.093341,"median":23.36123,"eighty":25.523906,"marketCap":5014966454},{"date":"2025-11-14","current":25.813341,"twenty":16.136723,"median":23.428153,"eighty":25.800484,"marketCap":4671182138},{"date":"2025-11-21","current":22.66771,"twenty":16.383495,"median":23.439945,"eighty":25.708429,"marketCap":4101948761},{"date":"2025-11-28","current":25.92045,"twenty":16.548957,"median":23.449096,"eighty":25.737913,"marketCap":4690564637},{"date":"2025-12-05","current":26.630754,"twenty":16.561288,"median":23.487393,"eighty":25.810359,"marketCap":4819101206},{"date":"2025-12-12","current":28.527716,"twenty":16.749451,"median":23.659866,"eighty":25.855971,"marketCap":5162375455},{"date":"2025-12-19","current":24.578765,"twenty":17.031279,"median":23.716749,"eighty":25.83416,"marketCap":4447773340},{"date":"2025-12-26","current":25.272157,"twenty":17.057186,"median":23.738426,"eighty":25.81185,"marketCap":4573249514},{"date":"2026-01-02","current":24.116504,"twenty":17.112011,"median":23.784087,"eighty":25.805886,"marketCap":4364122557},{"date":"2026-01-09","current":24.601314,"twenty":17.164381,"median":23.827333,"eighty":25.805886,"marketCap":4451853866},{"date":"2026-01-16","current":25.170685,"twenty":17.266247,"median":23.880592,"eighty":25.796882,"marketCap":4554887147},{"date":"2026-01-23","current":25.948637,"twenty":17.540977,"median":23.951744,"eighty":25.84491,"marketCap":4695665294},{"date":"2026-01-30","current":25.940181,"twenty":17.774022,"median":24.037581,"eighty":25.850684,"marketCap":4694135097},{"date":"2026-02-06","current":25.07485,"twenty":19.358663,"median":24.060792,"eighty":25.850684,"marketCap":4537544912},{"date":"2026-02-13","current":28.544628,"twenty":19.856695,"median":24.113685,"eighty":25.941872,"marketCap":5165435850},{"date":"2026-02-20","current":29.463513,"twenty":19.895332,"median":24.116504,"eighty":26.181969,"marketCap":5331717284},{"date":"2026-02-27","current":30.881602,"twenty":20.109789,"median":24.148919,"eighty":26.329202,"marketCap":6230980793},{"date":"2026-03-06","current":28.303079,"twenty":20.437519,"median":24.175424,"eighty":26.394077,"marketCap":5710712259},{"date":"2026-03-13","current":28.548292,"twenty":20.677847,"median":24.216336,"eighty":26.448787,"marketCap":5760188776},{"date":"2026-03-20","current":29.706099,"twenty":20.774883,"median":24.279418,"eighty":26.529401,"marketCap":5993799549},{"date":"2026-03-27","current":29.094332,"twenty":20.948708,"median":24.302633,"eighty":26.689853,"marketCap":5870363289},{"date":"2026-04-02","current":31.722344,"twenty":21.188418,"median":24.333318,"eighty":26.916253,"marketCap":6400617392},{"date":"2026-04-10","current":32.972012,"twenty":21.438642,"median":24.367365,"eighty":27.26095,"marketCap":6652762926},{"date":"2026-04-17","current":32.00567,"twenty":21.599983,"median":24.390836,"eighty":27.510741,"marketCap":6457783991},{"date":"2026-04-24","current":34.487298,"twenty":21.74531,"median":24.416095,"eighty":27.668065,"marketCap":6958502145},{"date":"2026-05-01","current":37.295257,"twenty":21.859509,"median":24.449388,"eighty":27.82041,"marketCap":7525063972},{"date":"2026-05-08","current":36.192948,"twenty":22.013131,"median":24.514222,"eighty":27.962617,"marketCap":8086011222},{"date":"2026-05-15","current":36.814364,"twenty":22.04773,"median":24.569427,"eighty":28.043615,"marketCap":8224844390},{"date":"2026-05-22","current":34.431506,"twenty":22.058695,"median":24.629872,"eighty":28.172029,"marketCap":7692480440},{"date":"2026-05-29","current":34.614275,"twenty":22.087907,"median":24.649232,"eighty":28.276876,"marketCap":7733313725},{"date":"2026-06-05","current":35.356777,"twenty":22.179879,"median":24.701718,"eighty":28.451451,"marketCap":7899198944},{"date":"2026-06-12","current":32.827703,"twenty":22.215687,"median":24.735008,"eighty":28.547559,"marketCap":7334168366},{"date":"2026-06-18","current":35.240261,"twenty":22.309869,"median":24.784071,"eighty":28.770121,"marketCap":7873167725},{"date":"2026-06-26","current":37.367242,"twenty":22.309869,"median":24.890996,"eighty":28.957822,"marketCap":8348365077},{"date":"2026-07-02","current":34.502329,"twenty":22.363139,"median":24.956422,"eighty":29.28494,"marketCap":7708303338},{"date":"2026-07-10","current":31.67397,"twenty":22.393278,"median":24.973378,"eighty":29.488267,"marketCap":7076408255},{"date":"2026-07-17","current":30.718999,"twenty":22.499929,"median":25.033154,"eighty":29.681878,"marketCap":6863054342},{"date":"2026-07-24","current":31.5209,"twenty":22.526829,"median":25.094581,"eighty":30.04842,"marketCap":7042210379},{"date":"2026-07-31","current":28.087116,"twenty":22.572171,"median":25.117084,"eighty":29.95643,"marketCap":6275055041},{"date":"2026-08-07","current":28.000114,"twenty":22.613938,"median":25.15941,"eighty":30.056374,"marketCap":7124937037},{"date":"2026-08-14","current":27.592745,"twenty":22.632287,"median":25.200171,"eighty":29.95643,"marketCap":7021277450},{"date":"2026-08-21","current":25.148529,"twenty":22.654015,"median":25.245022,"eighty":29.879492,"marketCap":6399319927},{"date":"2026-08-28","current":24.289642,"twenty":22.666157,"median":25.200171,"eighty":29.769879,"marketCap":6180766709},{"date":"2026-09-04","current":23.087602,"twenty":22.666157,"median":25.159607,"eighty":29.687933,"marketCap":5874894331},{"date":"2026-09-11","current":23.123724,"twenty":22.672158,"median":25.142499,"eighty":29.663665,"marketCap":5884085822},{"date":"2026-09-18","current":22.744449,"twenty":22.649109,"median":25.094581,"eighty":29.643692,"marketCap":5787575172},{"date":"2026-09-25","current":23.418715,"twenty":22.665381,"median":25.033154,"eighty":29.619567,"marketCap":5959149661},{"date":"2026-10-02","current":24.006691,"twenty":22.672158,"median":24.973378,"eighty":29.537776,"marketCap":6108766700}],"updateTime":1791036420794},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ECG\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672073955","title":"Quest Diagnostics (DGX) Could Be 6% Undervalued After Florida ECG Screening Push","url":"https://stock-news.laohu8.com/highlight/detail?id=2672073955","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672073955?lang=en_us&edition=fundamental","pubTime":"2026-10-01 10:23","pubTimestamp":1790821408,"startTime":"0","endTime":"0","summary":"Florida ECG mandate puts Quest Diagnostics in the spotlight\nQuest Diagnostics (DGX) is in focus after partnering with Who We Play For and other health groups on a cardiac screening program at its Tampa Sheldon Road site for Florida high school athletes.\nThe initiative supports Florida’s Second Chance Act, which from July 1, 2026 will require ECG heart checks for student athletes. The pilot targets up to 1,000 screenings by late November, with organizers planning a broader Southeast...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6032000-choice1-card/1788942533039","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6032000-choice1-card/1788942533039"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-dgx/quest-diagnostics/news/quest-diagnostics-dgx-could-be-6-undervalued-after-florida-e","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-dgx/quest-diagnostics/news/quest-diagnostics-dgx-could-be-6-undervalued-after-florida-e","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1854104046.USD","LU2506951875.HKD","LU0566484027.USD","LU0823417737.USD","LU1854103824.USD","ECG","LU0950375773.USD","BK4583","BK4129","BK4567","BK4196","LU2506952170.USD","LU2506952097.USD","LU2506951958.HKD","BK4588","LU1559883803.SGD","LU0823417653.USD","BK4585","DGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669934134","title":"Milestone Pharmaceuticals Enrolls First Canadian Study Participant in ReVeRA-301 Phase 3 Pivotal Trial Evaluating Etripamil Nasal Spray for AFib-RVR","url":"https://stock-news.laohu8.com/highlight/detail?id=2669934134","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669934134?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:00","pubTimestamp":1790251200,"startTime":"0","endTime":"0","summary":"Montreal Heart Institute Joins Multinational Study Evaluating a Self-Administered 70 mg Repeat-Dose Regimen of EtripamilMONTREAL and CHARLOTTE, N.C., Sept.  24, 2026 (GLOBE NEWSWIRE) -- Milestone Phar","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/24/3368250/0/en/milestone-pharmaceuticals-enrolls-first-canadian-study-participant-in-revera-301-phase-3-pivotal-trial-evaluating-etripamil-nasal-spray-for-afib-rvr.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","VR","IDNA","BK4129","MEDX","BK4585","LU1559883803.SGD","NVIB","LU0566484027.USD","GDOC","HYLG","AV","ECG","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666377380","title":"Everus Construction Group - Enters First Amendment to Credit Agreement on Sept 1, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2666377380","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666377380?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:12","pubTimestamp":1788898340,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nFWN4500Y9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ECG","LU0566484027.USD","BK4129","LU1559883803.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666377335","title":"Everus Construction Group - Increases Term Loans by $200 Mln to Total $477.50 Mln - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2666377335","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666377335?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:12","pubTimestamp":1788898340,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nFWN4500Y9:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ECG","LU0566484027.USD","BK4129","LU1559883803.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666377849","title":"Everus Construction Amends JPMorgan-Led Credit Agreement, Ups Term Loan to $477.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2666377849","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666377849?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:09","pubTimestamp":1788898181,"startTime":"0","endTime":"0","summary":"Everus Construction amends JPMorgan-led credit agreement, ups term loan to $477.5 millionEverus Construction Group entered a first amendment on Sept. 1, 2026 to its Oct. 31, 2024 credit agreement with","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL8cdxng:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0566484027.USD","BK4129","LU1559883803.SGD","ECG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664490368","title":"Everus Construction Group Management to Attend Jefferies Renewables and D.A. Davidson Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2664490368","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664490368?lang=en_us&edition=fundamental","pubTime":"2026-09-03 04:30","pubTimestamp":1788381033,"startTime":"0","endTime":"0","summary":"Everus Construction Group management to attend Jefferies renewables and D.A. Davidson investor conferencesEverus Construction Group management will attend the Jefferies Renewables, Clean Energy & Cons","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL4hyQTL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4129","LU1559883803.SGD","ECG","LU0566484027.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664281816","title":"Everus Closes $295 Million Cash Acquisition of Epsilon Industries","url":"https://stock-news.laohu8.com/highlight/detail?id=2664281816","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664281816?lang=en_us&edition=fundamental","pubTime":"2026-09-02 18:00","pubTimestamp":1788343207,"startTime":"0","endTime":"0","summary":"Everus Construction  closed its $295 million cash acquisition of Epsilon Industries, a designer and manufacturer of modular mechanical and electrical building infrastructure systems, Everus said late Tuesday.Everus plans to update its 2026 financial outlook, including the impact of Epsilon, with its Q3 earnings reporting, it said.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7064","LU0566484027.USD","ECG","ECG.AU","LU1559883803.SGD","BK4129"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664864866","title":"Everus Completes Acquisition of Epsilon Industries","url":"https://stock-news.laohu8.com/highlight/detail?id=2664864866","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664864866?lang=en_us&edition=fundamental","pubTime":"2026-09-02 06:20","pubTimestamp":1788301200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nTUA99K9XR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1559883803.SGD","BK4129","ECG","LU0566484027.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664648168","title":"Everus Construction Group - to Update Fy2026 Financial Forecast Including Epsilon Impact During Q3 Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2664648168","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664648168?lang=en_us&edition=fundamental","pubTime":"2026-09-02 06:20","pubTimestamp":1788301200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nTUA99K9XR:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1559883803.SGD","BK4129","LU0566484027.USD","ECG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663013954","title":"How Rising Analyst Earnings Estimates At Everus Construction Group (ECG) Have Changed Its Investment Story","url":"https://stock-news.laohu8.com/highlight/detail?id=2663013954","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663013954?lang=en_us&edition=fundamental","pubTime":"2026-08-29 02:39","pubTimestamp":1787942374,"startTime":"0","endTime":"0","summary":"In recent days, analysts have revised their earnings estimates higher for Everus Construction Group, Inc. (NYSE: ECG), reflecting increased optimism about the company’s earnings outlook. \nThis broad-based shift in expectations, paired with a top-tier Zacks Rank #1 (Strong Buy), suggests analysts see its earnings power differently than before. \nWith analysts increasingly aligned in raising earnings estimates, we’ll now examine how this improved sentiment interacts with Everus Construction...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/3041000-choice1-main-header/1585186744280","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3041000-choice1-main-header/1585186744280"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/capital-goods/nyse-ecg/everus-construction-group/news/how-rising-analyst-earnings-estimates-at-everus-construction","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/capital-goods/nyse-ecg/everus-construction-group/news/how-rising-analyst-earnings-estimates-at-everus-construction","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ECG","ECG.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662843720","title":"Everus Construction Group (ECG) Could Be 32% Below Fair Value Following Analyst Upgrades","url":"https://stock-news.laohu8.com/highlight/detail?id=2662843720","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662843720?lang=en_us&edition=fundamental","pubTime":"2026-08-27 11:32","pubTimestamp":1787801529,"startTime":"0","endTime":"0","summary":"Everus Construction Group (ECG) moved into focus after analysts collectively raised their earnings estimates, and the stock was identified as a top pick in recent research screens.\nAt a recent share price of $121.18, Everus Construction Group has seen mixed momentum, with the share price return down 6.47% over the past week and 20.02% over the past 90 days, yet still up 35.88% year to date and supported by a 56.71% total shareholder return over the past year. This suggests that recent...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/3041000-choice1-main-header/1585186744280","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3041000-choice1-main-header/1585186744280"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/capital-goods/nyse-ecg/everus-construction-group/news/everus-construction-group-ecg-could-be-32-below-fair-value-f","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/capital-goods/nyse-ecg/everus-construction-group/news/everus-construction-group-ecg-could-be-32-below-fair-value-f","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ECG","ECG.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661500294","title":"Everus Construction Group Initiated at Buy by DA Davidson","url":"https://stock-news.laohu8.com/highlight/detail?id=2661500294","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661500294?lang=en_us&edition=fundamental","pubTime":"2026-08-22 01:05","pubTimestamp":1787331900,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ECG/analyst-ratings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1559883803.SGD","BK4129","ECG","LU0566484027.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661260742","title":"Milestone Pharmaceuticals Initiates Pivotal Phase 3 Trial of Etripamil Nasal Spray for Self-Administered Treatment of Atrial Fibrillation with Rapid Ventricular Rate (AFib-RVR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2661260742","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661260742?lang=en_us&edition=fundamental","pubTime":"2026-08-21 20:00","pubTimestamp":1787313600,"startTime":"0","endTime":"0","summary":"ReVeRA-301 Trial is Evaluating the Same 70 mg Repeat-Dose Regimen that is FDA Approved for Paroxysmal Supraventricular Tachycardia (PSVT) Research Builds on Phase 2 Findings that Etripamil 70 mg Dose ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/21/3349033/0/en/milestone-pharmaceuticals-initiates-pivotal-phase-3-trial-of-etripamil-nasal-spray-for-self-administered-treatment-of-atrial-fibrillation-with-rapid-ventricular-rate-afib-rvr.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","FXU","VHT","LABU","BK4208","LU0566484027.USD","ECG","ED","LU1559883803.SGD","BK4129","VR","AV","BK4550","LU0170899867.USD","BK4585","LU2346227817.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661250734","title":"U.S. Research Roundup-Health Catalyst, Nektar Therapeutics, TIC Solutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2661250734","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661250734?lang=en_us&edition=fundamental","pubTime":"2026-08-21 15:26","pubTimestamp":1787297213,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Health Catalyst, Nektar Therapeutics, TIC SolutionsAug 21 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, incl","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nL8N44I09H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FTAI","IMA","ECG","TRFK","INNV","DISK","MRVL","AVGU","IXN","DOCS","AMYY","LEGR","BCAL","HL","DV","PI","ADI","CHAT","AMD","FIX","GTLB","LYTS","HRZN","MATW","AVGO","HCAT","MBX","EBS","MCHP","MTSI","VEGI","QBTS","CTEV","FERG","AAP","ADSK","FTH","BAI","MU","BWMN","EGGY","P","SMHX","ACEL","LMB","APP","COTY","ABT","AMP","DE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661232026","title":"Everus Construction initiated with a Buy at DA Davidson","url":"https://stock-news.laohu8.com/highlight/detail?id=2661232026","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661232026?lang=en_us&edition=fundamental","pubTime":"2026-08-21 04:30","pubTimestamp":1787257844,"startTime":"0","endTime":"0","summary":"DA Davidson analyst Kurt Yinger initiated coverage of Everus Construction (ECG) with a Buy rating and $168 price target The company is hitting thei...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/everus-construction-initiated-with-a-buy-at-da-davidson-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/everus-construction-initiated-with-a-buy-at-da-davidson-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ECG","LU0566484027.USD","BK4129","LU1559883803.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660421466","title":"U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Patients with Tourette Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2660421466","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660421466?lang=en_us&edition=fundamental","pubTime":"2026-08-19 20:30","pubTimestamp":1787142600,"startTime":"0","endTime":"0","summary":"Ecopipam(EBS-101) is a first-in-class selective D1 (dopamine) receptor antagonist with Orphan Drug designationNDA acceptance is supported by positive Phase 3 data, which were published in JAMA Neurolo","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/19/3347619/0/en/u-s-fda-accepts-teva-s-new-drug-application-nda-and-grants-priority-review-for-ecopipam-a-first-in-class-investigational-therapy-for-pediatric-patients-with-tourette-syndrome.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0566484027.USD","ECG","BK4588","BK4157","BK4585","AIMS","LABU","BMI","LU1559883803.SGD","BK4129"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660449820","title":"Everus Construction Director David M. Sparby Acquires 1,000 Common Shares for $144,950","url":"https://stock-news.laohu8.com/highlight/detail?id=2660449820","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660449820?lang=en_us&edition=fundamental","pubTime":"2026-08-18 22:13","pubTimestamp":1787062429,"startTime":"0","endTime":"0","summary":"Everus Construction director David M. Sparby acquires 1,000 common shares for $144,950Everus Construction Group director David M. Sparby bought 1,000 shares of common stock at USD 144.95.Direct holdin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDL1KN3jG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Everus Construction Director David M. Sparby Acquires 1,000 Common Shares for $144,950","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1559883803.SGD","BK4129","ECG","LU0566484027.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660150464","title":"NeuralCloud to Pilot AI ECG Platforms with Island Mobile Cardiology Testing","url":"https://stock-news.laohu8.com/highlight/detail?id=2660150464","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660150464?lang=en_us&edition=fundamental","pubTime":"2026-08-18 19:43","pubTimestamp":1787053386,"startTime":"0","endTime":"0","summary":"The latest update is out from Aiml Resources ( ($TSE:AIML) ). NeuralCloud Solutions Inc., a subsidiary of AI/ML Innovations Inc., has signed a non-...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/neuralcloud-to-pilot-ai-ecg-platforms-with-island-mobile-cardiology-testing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/neuralcloud-to-pilot-ai-ecg-platforms-with-island-mobile-cardiology-testing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0566484027.USD","AIPO","ECG","AGIX","ARTY","CHAT","QTOC","VTHR","LU1559883803.SGD","BK4129"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659152681","title":"Everus Construction Group Price Target Cut to $152.00/Share from $174.00 by Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2659152681","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659152681?lang=en_us&edition=fundamental","pubTime":"2026-08-13 20:34","pubTimestamp":1786624440,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ECG/analyst-ratings","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ECG","LU0566484027.USD","BK4129","LU1559883803.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658908917","title":"Milestone Pharmaceuticals Announces Second Quarter 2026 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2658908917","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658908917?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:08","pubTimestamp":1786532880,"startTime":"0","endTime":"0","summary":"Over 50% of commercially insured lives in the U.S., representing a recent and significant increase, now have coverage for CARDAMYST (etripamil) nasal spray Phase 3 registrational trial of etripamil fo","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/12/3343531/0/en/milestone-pharmaceuticals-announces-second-quarter-2026-financial-results-and-provides-corporate-update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4129","LU1559883803.SGD","LU0566484027.USD","AV","EMA","ECG","BK4081"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":88,"code":"91000000","status":"200"}]}}